Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine in patients with Non Small Cell Lung Cancer
refractory to previous chemotherapy whether concomitant treatment with cetuximab and
pemetrexed improves progression-free survival compared with cetuximab monotherapy.